210 related articles for article (PubMed ID: 34224305)
1. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3β axis.
Huang L; Chen J; Quan J; Xiang D
Bioengineered; 2021 Dec; 12(1):3065-3076. PubMed ID: 34224305
[TBL] [Abstract][Full Text] [Related]
2. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway.
Ma Z; Yang J; Yang Y; Wang X; Chen G; Shi A; Lu Y; Jia S; Kang X; Lu L
Phytomedicine; 2020 Mar; 68():153186. PubMed ID: 32088353
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.
Wang XJ; Feng CW; Li M
Mol Cell Biochem; 2013 Aug; 380(1-2):57-66. PubMed ID: 23625205
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of ADAM17 inhibits cell proliferation and increases oxaliplatin sensitivity in HCT-8 colorectal cancer through EGFR-PI3K-AKT activation.
Zhang Q; Wang C; Han X; Yang G; Ge Z; Zhang G
Biochem Biophys Res Commun; 2018 Sep; 503(4):2333-2339. PubMed ID: 29964008
[TBL] [Abstract][Full Text] [Related]
5. Detailed studies on the anticancer action of rosmarinic acid in human Hep-G2 liver carcinoma cells: evaluating its effects on cellular apoptosis, caspase activation and suppression of cell migration and invasion.
Jin B; Liu J; Gao D; Xu Y; He L; Zang Y; Li N; Lin D
J BUON; 2020; 25(3):1383-1389. PubMed ID: 32862580
[TBL] [Abstract][Full Text] [Related]
6. Rosmarinic acid inhibits cell proliferation, migration, and invasion and induces apoptosis in human glioma cells.
Liu Y; Xu X; Tang H; Pan Y; Hu B; Huang G
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649774
[TBL] [Abstract][Full Text] [Related]
7. Rosmarinic Acid Analogue-11 Induces Apoptosis of Human Gastric Cancer SGC-7901 Cells via the Epidermal Growth Factor Receptor (EGFR)/Akt/Nuclear Factor kappa B (NF-κB) Pathway.
Li W; Li Q; Wei L; Pan X; Huang D; Gan J; Tang S
Med Sci Monit Basic Res; 2019 Feb; 25():63-75. PubMed ID: 30799435
[TBL] [Abstract][Full Text] [Related]
8. Rosmarinic Acid Induces Proliferation Suppression of Hepatoma Cells Associated with NF-κB Signaling Pathway.
An Y; Zhao J; Zhang Y; Wu W; Hu J; Hao H; Qiao Y; Tao Y; An L
Asian Pac J Cancer Prev; 2021 May; 22(5):1623-1632. PubMed ID: 34048194
[TBL] [Abstract][Full Text] [Related]
9. Rosmarinic inhibits cell proliferation, invasion and migration via up-regulating miR-506 and suppressing MMP2/16 expression in pancreatic cancer.
Han Y; Ma L; Zhao L; Feng W; Zheng X
Biomed Pharmacother; 2019 Jul; 115():108878. PubMed ID: 31060006
[TBL] [Abstract][Full Text] [Related]
10. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
12. PDIA6 regulation of ADAM17 shedding activity and EGFR-mediated migration and invasion of glioblastoma cells.
Kim TW; Ryu HH; Li SY; Li CH; Lim SH; Jang WY; Jung S
J Neurosurg; 2017 Jun; 126(6):1829-1838. PubMed ID: 27540907
[TBL] [Abstract][Full Text] [Related]
13. [ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad].
Chen Y; Zheng K; Chen Z; Feng H; Fang W; Huang Z
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Nov; 38(11):1366-1371. PubMed ID: 30514687
[TBL] [Abstract][Full Text] [Related]
14. Rosmarinic acid inhibits proliferation and invasion of hepatocellular carcinoma cells SMMC 7721 via PI3K/AKT/mTOR signal pathway.
Wang L; Yang H; Wang C; Shi X; Li K
Biomed Pharmacother; 2019 Dec; 120():109443. PubMed ID: 31541884
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro.
Li YQ; Liu YS; Ying XW; Zhou HB; Wang Z; Wu SC; Yan JP; Jing YT; Yang Y
Biotechnol Prog; 2018 Jan; 34(1):196-205. PubMed ID: 28960861
[TBL] [Abstract][Full Text] [Related]
16. ADAM17-siRNA inhibits MCF-7 breast cancer through EGFR-PI3K-AKT activation.
Meng X; Hu B; Hossain MM; Chen G; Sun Y; Zhang X
Int J Oncol; 2016 Aug; 49(2):682-90. PubMed ID: 27221510
[TBL] [Abstract][Full Text] [Related]
17. Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation.
Huang Y; Benaich N; Tape C; Kwok HF; Murphy G
Int J Biol Sci; 2014; 10(7):702-14. PubMed ID: 25013379
[TBL] [Abstract][Full Text] [Related]
18. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.
He P; Wang Z; Sheng B; Xu Y; Feng S; Huang Y; Gong F; Tang L; Xie L
Histol Histopathol; 2020 Dec; 35(12):1511-1520. PubMed ID: 33372687
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer.
Nam KH; Yi SA; Nam G; Noh JS; Park JW; Lee MG; Park JH; Oh H; Lee J; Lee KR; Park HJ; Lee J; Han JW
BMC Cancer; 2019 Aug; 19(1):773. PubMed ID: 31387554
[TBL] [Abstract][Full Text] [Related]
20. RNA silencing of integrin-linked kinase increases the sensitivity of the A549 lung cancer cell line to cisplatin and promotes its apoptosis.
Zhao X; Xu Z; Wang Z; Wu Z; Gong Y; Zhou L; Xiang Y
Mol Med Rep; 2015 Jul; 12(1):960-6. PubMed ID: 25760437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
